BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, X0
Reports Recent Business Progress and Third Quarter 2025 Financial Results
Strengthens Board of Directors with New Appointments
Reports Recent Business Progress and Second Quarter 2025 Financial Results
Shareholder votes
Reports Recent Business Progress and First Quarter 2025 Financial Results
Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
Annual Report to Security Holders
Announces New Board and Key Clinical Leadership Appointments
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities